1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cardiac Toxicity

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Cardiac Toxicity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Wang, J; Xu, R; Xuan, C; Xuan, L; Yan, W	1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cardiac Toxicity

Article	Year
BN52021 protects rat cardiomyocyte from doxorubicin induced cardiotoxicity. International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:2 Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Blotting, Western; Cardiomyopathies; Cardiotoxicity; Cell Line; Cell Survival; Doxorubicin; Ginkgolides; In Situ Nick-End Labeling; Myocytes, Cardiac; Platelet Activating Factor; Rats	2015

Article

Year

BN52021 protects rat cardiomyocyte from doxorubicin induced cardiotoxicity.

International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:2

Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Blotting, Western; Cardiomyopathies; Cardiotoxicity; Cell Line; Cell Survival; Doxorubicin; Ginkgolides; In Situ Nick-End Labeling; Myocytes, Cardiac; Platelet Activating Factor; Rats

2015